Gut microbiota and its metabolic products in acute respiratory distress syndrome

Gut microbiota and its metabolic products in acute respiratory distress syndrome

The prevalence rate of acute respiratory distress syndrome (ARDS) is estimated at approximately 10% in critically ill patients worldwide, with the mortality rate ranging from 17% to 39%. Currently, ARDS mortality is usually higher in patients with COVID-19, giving another challenge for ARDS treatmen...

Full description

Bibliographic Details
Main Authors: Dong-Wei Zhang, Jia-Li Lu, Bi-Ying Dong, Meng-Ying Fang, Xia Xiong, Xue-Jun Qin, Xian-Ming Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Immunology
Subjects:
acute respiratory distress syndrome (ARDS)
gut microbiota
metabolic products
gut-lung
axis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1330021/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1330021/full

Similar Items